Publications in collaboration with researchers from Hospital Universitario Puerta de Hierro (32)

2024

  1. Combinational Diuretics in Heart Failure

    Current Heart Failure Reports

  2. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

    Diabetes and Metabolism, Vol. 50, Núm. 1

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial

    European urology oncology, Vol. 6, Núm. 1, pp. 58-66

2022

  1. Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  3. Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 11, pp. 2253-2263

  4. Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 1, pp. 1-9

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  2. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients

    Scientific Reports, Vol. 11, Núm. 1

  3. Initiation and titration of sacubitril/valsartan in different types of centers

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97

  4. Long-term survival of mechanically ventilated patients with severe COVID-19: an observational cohort study

    Annals of Intensive Care, Vol. 11, Núm. 1

  5. Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients

    ESC Heart Failure, Vol. 8, Núm. 4, pp. 2713-2722

2020

  1. Clinical benefit of tamsulosin and the hexanic extract of serenoa repens, in combination or as monotherapy, in patients with moderate/severe luts-bph: A subset analysis of the qualiprost study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14

  2. Epstein–Barr virus-associated large B-cell lymphoma transformation in marginal zone B-cell lymphoma: a series of four cases

    Histopathology, Vol. 77, Núm. 1, pp. 112-122

  3. Genotypic and phenotypic characteristics of staphylococcus aureus prosthetic joint infections: Insight on the pathogenesis and prognosis of a multicenter prospective cohort

    Open Forum Infectious Diseases, Vol. 7, Núm. 9

  4. Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 368-375

  5. Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 145, Núm. 5, pp. 275-282

2019

  1. Continuous Positive Airway Pressure Treatment Does not Reduce Uric Acid Levels in OSA Women

    Archivos de Bronconeumologia, Vol. 55, Núm. 4, pp. 201-207

  2. Sacubitril/Valsartan in Daily Clinical Practice: Data from a Prospective Registry

    Journal of Cardiovascular Pharmacology, Vol. 73, Núm. 2, pp. 118-124